Dietary aldose reductase inhibitors and prevention of diabetic complications

Prolonged exposure to hyperglycemia can lead to the development of complications such as cataracts, retinopathy, neuropathy, and nephropathy. Several mechanisms are supposed to be involved in this process such as increased aldose reductase (AR)-related polyol pathway, increased formation of advanced...

Full description

Bibliographic Details
Main Authors: Ameena Anjum, Janamolla Sreeja, Yarlagadda Swapna, Rajesh Bolleddu, Sama Venkatesh
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Health Sciences and Biomedical Research KLEU
Subjects:
Online Access:http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2021;volume=14;issue=2;spage=194;epage=199;aulast=Anjum
_version_ 1819104622292238336
author Ameena Anjum
Janamolla Sreeja
Yarlagadda Swapna
Rajesh Bolleddu
Sama Venkatesh
author_facet Ameena Anjum
Janamolla Sreeja
Yarlagadda Swapna
Rajesh Bolleddu
Sama Venkatesh
author_sort Ameena Anjum
collection DOAJ
description Prolonged exposure to hyperglycemia can lead to the development of complications such as cataracts, retinopathy, neuropathy, and nephropathy. Several mechanisms are supposed to be involved in this process such as increased aldose reductase (AR)-related polyol pathway, increased formation of advanced glycation end products, and excessive oxidation stress in the body. AR is the principal enzyme of the polyol pathway in the development of secondary complications of diabetes, and its inhibition provides a significant strategy to prevent these complications. Synthetic aldose reductase inhibitors (ARIs) have been developed, but they suffer drawbacks and safety issues demanding research on natural sources for potential ARIs. Many dietary substances and phytochemicals were reported as being good source of ARIs including Spinacia oleracea, Ocimum sanctum, Foeniculum vulgare, Momordica charantia, Cinamomum zeylencium, and Cuminum cyminum. This review was undertaken to provide an insight into the use of dietary ARIs for prevention, delay, or management of the secondary complications and to serve as a guide for further research for their optimum and effective use and also to create awareness among the diabetics.
first_indexed 2024-12-22T02:09:17Z
format Article
id doaj.art-beaf384473024568ba84a4d0d0e3e03c
institution Directory Open Access Journal
issn 2542-6214
2542-6222
language English
last_indexed 2024-12-22T02:09:17Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Health Sciences and Biomedical Research KLEU
spelling doaj.art-beaf384473024568ba84a4d0d0e3e03c2022-12-21T18:42:27ZengWolters Kluwer Medknow PublicationsIndian Journal of Health Sciences and Biomedical Research KLEU2542-62142542-62222021-01-0114219419910.4103/kleuhsj.kleuhsj_105_19Dietary aldose reductase inhibitors and prevention of diabetic complicationsAmeena AnjumJanamolla SreejaYarlagadda SwapnaRajesh BolledduSama VenkateshProlonged exposure to hyperglycemia can lead to the development of complications such as cataracts, retinopathy, neuropathy, and nephropathy. Several mechanisms are supposed to be involved in this process such as increased aldose reductase (AR)-related polyol pathway, increased formation of advanced glycation end products, and excessive oxidation stress in the body. AR is the principal enzyme of the polyol pathway in the development of secondary complications of diabetes, and its inhibition provides a significant strategy to prevent these complications. Synthetic aldose reductase inhibitors (ARIs) have been developed, but they suffer drawbacks and safety issues demanding research on natural sources for potential ARIs. Many dietary substances and phytochemicals were reported as being good source of ARIs including Spinacia oleracea, Ocimum sanctum, Foeniculum vulgare, Momordica charantia, Cinamomum zeylencium, and Cuminum cyminum. This review was undertaken to provide an insight into the use of dietary ARIs for prevention, delay, or management of the secondary complications and to serve as a guide for further research for their optimum and effective use and also to create awareness among the diabetics.http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2021;volume=14;issue=2;spage=194;epage=199;aulast=Anjumaldose reductase inhibitorsdiabetesdiabetic complicationsphytochemicals
spellingShingle Ameena Anjum
Janamolla Sreeja
Yarlagadda Swapna
Rajesh Bolleddu
Sama Venkatesh
Dietary aldose reductase inhibitors and prevention of diabetic complications
Indian Journal of Health Sciences and Biomedical Research KLEU
aldose reductase inhibitors
diabetes
diabetic complications
phytochemicals
title Dietary aldose reductase inhibitors and prevention of diabetic complications
title_full Dietary aldose reductase inhibitors and prevention of diabetic complications
title_fullStr Dietary aldose reductase inhibitors and prevention of diabetic complications
title_full_unstemmed Dietary aldose reductase inhibitors and prevention of diabetic complications
title_short Dietary aldose reductase inhibitors and prevention of diabetic complications
title_sort dietary aldose reductase inhibitors and prevention of diabetic complications
topic aldose reductase inhibitors
diabetes
diabetic complications
phytochemicals
url http://www.ijournalhs.org/article.asp?issn=2542-6214;year=2021;volume=14;issue=2;spage=194;epage=199;aulast=Anjum
work_keys_str_mv AT ameenaanjum dietaryaldosereductaseinhibitorsandpreventionofdiabeticcomplications
AT janamollasreeja dietaryaldosereductaseinhibitorsandpreventionofdiabeticcomplications
AT yarlagaddaswapna dietaryaldosereductaseinhibitorsandpreventionofdiabeticcomplications
AT rajeshbolleddu dietaryaldosereductaseinhibitorsandpreventionofdiabeticcomplications
AT samavenkatesh dietaryaldosereductaseinhibitorsandpreventionofdiabeticcomplications